ClinicalTrials.Veeva
Menu

Find clinical trials for Prostate Cancer in Louisville, KY

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Prostatic Cancer
Cancer
Carcinoma
Hypersensitivity
Recurrence
Adenocarcinoma
Breast Cancer

Prostate Cancer trials near Louisville, KY, USA:

A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer

Prostate cancer is usually treated by reducing the amount of testosterone in the body. PRL-02 depot is a potential treatment for me ...

Enrolling
Metastatic Castration Resistant Prostate Cancer
Metastatic Castration-sensitive Prostate Cancer
Drug: prednisone
Drug: PRL-02 injection

Phase 1

Astellas
Astellas

Jeffersonville, Indiana, United States and 13 other locations

and abiraterone in patients with metastatic castration-resistant prostate cancer (mCRPC) who have received no prior cytotoxic chemo ...

Active, not recruiting
Metastatic Castration-resistant Prostate Cancer
Drug: abiraterone acetate
Drug: olaparib

Phase 3

AstraZeneca
AstraZeneca

Jeffersonville, Indiana, United States and 131 other locations

the safety and preliminary antitumor activity of ORIC-944 as a single agent and in combinations with ARPIs in patients with metastatic prostate...

Enrolling
Metastatic Prostate Cancer
Drug: Darolutamide (Nubeqa®) 300 mg tablets
Drug: ORIC-944

Phase 1

Oric Pharmaceuticals

Jeffersonville, Indiana, United States and 15 other locations

cemiplimab, or in combination with REGN5678. REGN4336, cemiplimab and REGN5678 are a type of treatment for cancer called immunotherapy,and ...

Enrolling
Metastatic Castration-resistant Prostate Cancer
Drug: Cemiplimab
Drug: Sarilumab

Phase 1, Phase 2

Regeneron Pharmaceuticals
Regeneron Pharmaceuticals

Louisville, Kentucky, United States and 10 other locations

The purpose of this study is to evaluate the efficacy and safety of apalutamide in adult men with high-risk non-metastatic castration-resistant prostate...

Active, not recruiting
Prostatic Neoplasms
Drug: Apalutamide
Drug: Placebo

Phase 3

Aragon Pharmaceuticals

Jeffersonville, Indiana, United States and 388 other locations

The purpose of this study is to collect long term safety data in subjects who are continuing to derive clinical benefit from treatment with Enzalutam...

Enrolling
Prostate Cancer
Drug: prednisone
Drug: enzalutamide

Phase 2

Astellas
Astellas

Jeffersonville, Indiana, United States and 233 other locations

in participants with high-risk, localized or locally advanced prostate cancer receiving primary radiation therapy (RT) results in a...

Active, not recruiting
Prostatic Neoplasms
Drug: Bicalutamide Placebo
Radiation: 74-80 Grays (units of radiation)

Phase 3

Aragon Pharmaceuticals

Jeffersonville, Indiana, United States and 271 other locations

The primary purpose of this study is to determine the pharmacokinetics (PK) and pharmacodynamics (PD) of Debio 4228.

Enrolling
Prostate Cancer
Drug: Debio 4228

Phase 2

Debiopharm
Debiopharm

Jeffersonville, Indiana, United States and 16 other locations

A Phase 1 Dose Escalation and Expanded Cohort Study Of PF-06821497 (Mevrometostat) in Adult Patients With Relapsed/Refractory Small Cell Lung Cancer...

Enrolling
Metastatic Castration Resistant Prostate Cancer (mCRPC)
Small Cell Lung Cancer (SCLC)
Drug: Enzalutamide
Drug: Mervometostat (PF-06821497)

Phase 1

Pfizer
Pfizer

Louisville, Kentucky, United States and 100 other locations

assess the safety and efficacy of nivolumab in combination with rucaparib, docetaxel, or enzalutamide in participants with castration-resistant prostate...

Active, not recruiting
Prostate Cancer
Biological: nivolumab
Drug: docetaxel

Phase 2

Bristol-Myers Squibb (BMS)
Bristol-Myers Squibb (BMS)

Louisville, Kentucky, United States and 65 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems